Evidence map›Paper›PMID 29895226›Full record

ArticleCell cycle (Georgetown, Tex.)2018

Down-regulation of circ-PRKCI inhibits cell migration and proliferation in Hirschsprung disease by suppressing the expression of miR-1324 target PLCB1.

Lingling Zhou, Yang Li, Weiwei Jiang, Hua Zhang, Zechao Wen, Yang Su, Feng Wu, Zhengke Zhi, Qiyang Shen, Hongxing Li and 2 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Pharmacogenomics and personalized medicine · 2020
    Article
  15. Epigenetic Mechanisms in Hirschsprung Disease.International journal of molecular sciences · 2019
    Review
  16. Role and mechanism of circ-PRKCI in hepatocellular carcinoma.World journal of gastroenterology · 2019
    Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Lingling Zhoua Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Yang Lia Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Weiwei Jianga Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Hua Zhanga Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Zechao Wena Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Yang Sua Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Feng Wua Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Zhengke Zhia Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Qiyang Shena Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Hongxing Lia Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Xiaoqun Xua Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.
Weibing Tanga Department of Pediatric Surgery , Children's Hospital of Nanjing Medical University , Nanjing , China.ORCID 0000-0002-3582-3408
Second Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are a novel class of noncoding RNAs (ncRNAs), which have been shown to participate in intracellular RNA regulatory networks and play vital roles in many pathological processes. Recently, circular RNA_PRKCI (circ-PRKCI) has been reported to regulate cell proliferation, migration and invasion in several human cancers. Hirschsprung disease (HSCR) is a well-known congenital gut motility disorder which roots in the aberrance of cranial-caudal neural crest cell migration. In this study, we investigated whether circ-PRKCI may affect cell migration and proliferation in HSCR. Quantitative reverse transcription PCR (qRT-PCR) was performed to detect the expression of circ-PRKCI in 48 HSCR aganglionic tissues and 48 normal bowel tissues. Luciferase reporter assay and RNA immunoprecipitation (RIP) assay verified the direct interaction between miR-1324 and PLCB1 or circ-PRKCI. Cell counting Kit-8 (CCK-8) and Ethynyldeoxyuridine (EdU) assays were employed to appraise the effects of miR-1324 or circ-PRKCI on cell proliferative potential, while transwell was performed to detect the migration in vitro. We found that circ-PRKCI was significantly down-regulated in HSCR aganglionic tissues. Morever, knockdown of circ-PRKCI suppressed cell proliferation and migration in vitro. Mechanistically, we confirmed that circ-PRKCI functioned as a molecular sponge for miR-1324 to upregulate the expression of PLCB1. In conclusion, our present study revealed the important role of circ-PRKCI-miR-1324-PLCB1 regulatory network in HSCR, providing a novel insight for the pathogenesis of HSCR.

Indexed as

Cell MovementCell ProliferationBinding SitesDown-RegulationFemaleGene SilencingHEK293 CellsHirschsprung DiseaseHumansInfantIsoenzymesMaleMicroRNAsPhospholipase C betaProtein Kinase CProtein Kinase C-lambdaIsoenzymesMicroRNAsMIRN1324 microRNA, humanPhospholipase C betaPLCB1 protein, humanProtein Kinase CProtein Kinase C-lambdaRNA, Circularcircular RNA_PRKCIHirschsprung diseasemigrationmiR-1324proliferation

Identifiers

PMID29895226
PMCPMC6110588
OpenAlexW2808474402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.